av/prothena-corporation--big.svg

COM:PROTHENA

Prothena Biosciences

  • Stock

USD

Last Close

14.44

22/11 21:00

Market Cap

1.13B

Beta: -

Volume Today

468.84K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-140.50K
-
-908.50K
546.62%
-1.13M
24.82%
-343.50K
69.71%
-209K
39.16%
-120K
42.58%
-34K
71.67%
642K
1,988.24%
676K
5.30%
-31K
104.59%
-2.61M
8,320.97%
average payables
895K
-
3.26M
263.80%
4.62M
41.91%
8.79M
90.33%
13.35M
51.82%
7.55M
43.44%
1.36M
82.04%
2.68M
97.60%
3.90M
45.70%
6.48M
66.00%
17.33M
167.43%
average receivables
140.50K
-
908.50K
546.62%
1.13M
24.82%
343.50K
69.71%
209K
39.16%
121K
42.11%
35K
71.07%
41.50K
18.57%
7.50K
81.93%
31K
313.33%
2.61M
8,320.97%
book value per share
9.31
-
11.75
26.23%
11.89
1.22%
10.64
10.56%
10.81
1.66%
8.16
24.50%
6.84
16.19%
4.61
32.63%
10.54
128.58%
13.13
24.62%
10.55
19.67%
capex per share
-0.03
-
-0.02
29.63%
-0.05
113.75%
-0.48
963.23%
-0.10
80.13%
-0.04
53.59%
-0.01
68.86%
-0.00
64.71%
-0.01
164.76%
-0.01
24.66%
-0.05
439.06%
capex to depreciation
-0.85
-
-0.71
17.16%
-1.71
142.20%
-6.86
299.96%
-1.18
82.76%
-0.55
53.50%
-0.08
85.20%
-0.03
65.48%
-0.08
200.87%
-0.62
637.87%
-3.03
385.53%
capex to operating cash flow
0.02
-
0.77
4,282.92%
0.02
97.13%
0.14
541.41%
0.03
80.53%
0.06
126.21%
0.01
83.24%
0.00
76.72%
-0.01
354.58%
0.00
168.67%
0.02
392.15%
capex to revenue
-0.83
-
-0.01
98.76%
-0.86
8,214.41%
-15.78
1,734.48%
-0.13
99.16%
-1.85
1,305.02%
-0.68
63.17%
-0.23
66.30%
-0.00
98.75%
-0.01
200.26%
-0.03
257.28%
cash per share
9.49
-
11.90
25.37%
12.22
2.70%
11.26
7.83%
11.09
1.53%
10.81
2.53%
9.42
12.86%
7.40
21.45%
13.09
76.93%
15.00
14.54%
11.65
22.29%
days of inventory on hand
days payables outstanding
days sales outstanding
31.32
-
12.63
59.69%
115.61
815.72%
61.58
46.73%
3.18
94.83%
0.76
75.99%
30.49
3,888.94%
6.42
78.95%
0.42
-
20.61
4,809.07%
debt to assets
0.11
-
0.11
5.65%
0.10
1.83%
0.05
47.06%
0.05
2.08%
0.02
62.24%
0.01
57.78%
0.02
99.02%
debt to equity
0.14
-
0.13
8.64%
0.16
24.37%
0.08
47.33%
0.10
15.34%
0.03
72.72%
0.01
60.66%
0.02
102.60%
dividend yield
earnings yield
-0.08
-
-0.01
83.19%
-0.04
179.58%
-0.09
142.79%
-0.11
14.56%
-0.38
251.90%
-0.12
67.79%
-0.23
88.44%
0.03
113.22%
-0.04
233.68%
-0.08
85.54%
enterprise value
316.99M
-
218.61M
31.04%
1.69B
675.31%
1.35B
20.11%
1.05B
22.73%
31.34M
97.00%
278.55M
788.66%
201.84M
27.54%
1.62B
701.68%
2.15B
32.88%
1.33B
38.35%
enterprise value over ebitda
-7.84
-
-32.88
319.31%
-21.20
35.51%
-8.49
59.97%
-6.74
20.60%
-0.25
96.33%
-3.25
1,210.59%
-1.79
44.84%
22.48
1,355.67%
-16.34
172.70%
-6.97
57.34%
ev to operating cash flow
-9.88
-
-320.08
3,141.02%
-27.14
91.52%
-11.55
57.45%
-7.98
30.93%
-1.11
86.10%
-5.26
374.39%
-2.51
52.24%
17.47
795.70%
-19.76
213.07%
-9.90
49.90%
ev to sales
468.92
-
4.30
99.08%
1.05K
24,434.91%
1.28K
21.70%
38.02
97.04%
32.82
13.67%
342.20
942.59%
236.62
30.85%
8.07
96.59%
39.89
394.42%
14.51
63.63%
free cash flow per share
-1.75
-
-0.05
97.21%
-2.11
4,195.71%
-3.90
85.19%
-3.58
8.16%
-0.76
78.79%
-1.34
76.71%
-2.02
50.38%
2.08
203.10%
-2.31
210.88%
-2.57
11.36%
free cash flow yield
-0.07
-
-0.00
96.43%
-0.03
1,209.34%
-0.08
156.42%
-0.10
20.50%
-0.07
22.79%
-0.08
14.98%
-0.17
98.22%
0.04
125.07%
-0.04
190.91%
-0.07
84.62%
graham net net
9.00
-
11.34
25.99%
11.41
0.65%
8.51
25.43%
8.73
2.51%
6.37
27.03%
5.75
9.66%
3.69
35.93%
9.85
167.36%
12.13
23.08%
9.14
24.62%
graham number
21.48
-
8.75
59.24%
26.67
204.70%
33.40
25.23%
31.47
5.79%
26.89
14.56%
17.32
35.59%
16.99
1.86%
18.95
11.49%
27.01
42.54%
25.61
5.19%
income quality
0.78
-
0.10
87.80%
0.77
711.06%
0.73
5.46%
0.86
16.88%
0.18
78.78%
0.68
275.36%
0.72
6.03%
1.38
91.23%
0.93
32.70%
0.91
2.12%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
-0.05
Infinity%
interest coverage
-262.51
-
-42.10
-
-42.97
2.07%
-10.45
75.69%
19.65
-
interest debt per share
0.01
-
1.49
-
1.49
0.57%
1.40
5.99%
0.78
44.08%
0.45
42.77%
0.28
37.64%
-0.00
101.69%
0.22
4,824.06%
inventory turnover
invested capital
0.14
-
0.13
8.64%
0.16
24.37%
0.08
47.33%
0.10
15.34%
0.03
72.72%
0.01
60.66%
0.02
102.60%
market cap
493.67M
-
512.19M
3.75%
2.07B
303.27%
1.69B
18.19%
1.41B
16.46%
407.46M
71.14%
631.33M
54.94%
479.38M
24.07%
2.18B
355.77%
2.85B
30.63%
1.93B
32.24%
net current asset value
169.08M
-
285.05M
68.59%
352.84M
23.78%
296.79M
15.88%
337.19M
13.61%
255.59M
24.20%
232.03M
9.22%
150.31M
35.22%
441.49M
193.71%
583.11M
32.08%
504.26M
13.52%
net debt to ebitda
4.37
-
44.15
910.32%
4.64
89.50%
2.10
54.62%
2.35
11.87%
2.97
26.27%
4.11
38.33%
2.46
40.11%
-7.87
419.85%
5.35
167.95%
3.20
40.20%
net income per share
-2.20
-
-0.29
86.84%
-2.66
817.24%
-4.66
75.34%
-4.07
12.69%
-3.93
3.32%
-1.95
50.50%
-2.78
42.97%
1.51
154.38%
-2.47
263.04%
-2.76
11.91%
operating cash flow per share
-1.72
-
-0.03
98.39%
-2.06
7,339.36%
-3.41
65.76%
-3.48
2.05%
-0.71
79.48%
-1.33
85.81%
-2.01
51.59%
2.09
204.00%
-2.30
209.72%
-2.52
9.53%
payables turnover
receivables turnover
11.66
-
28.91
148.05%
3.16
89.08%
5.93
87.73%
114.66
1,834.59%
477.50
316.44%
11.97
97.49%
56.87
375.05%
869.44
-
17.71
97.96%
research and ddevelopement to revenue
38.54
-
0.76
98.04%
36.37
4,709.42%
113.30
211.57%
4.89
95.68%
105.95
2,067.02%
62.45
41.06%
87.79
40.57%
0.41
99.53%
2.51
513.02%
2.41
4.01%
return on tangible assets
-0.22
-
-0.02
89.54%
-0.21
790.03%
-0.35
66.34%
-0.31
11.30%
-0.31
1.07%
-0.19
40.63%
-0.33
80.17%
0.11
132.93%
-0.15
240.37%
-0.20
30.50%
revenue per share
0.04
-
2.06
5,575.93%
0.05
97.43%
0.03
42.04%
0.73
2,279.62%
0.02
96.70%
0.02
15.45%
0.02
4.70%
4.54
21,121.25%
1.14
74.91%
1.72
50.88%
roe
-0.24
-
-0.02
89.58%
-0.22
806.18%
-0.44
96.04%
-0.38
14.11%
-0.48
28.05%
-0.28
40.94%
-0.60
112.23%
0.14
123.79%
-0.19
230.82%
-0.26
39.31%
roic
-0.24
-
-0.03
89.02%
-0.22
764.22%
-0.34
53.55%
-0.30
14.07%
-0.37
25.99%
-0.27
27.33%
-0.51
89.49%
0.14
126.69%
-0.19
241.22%
-0.30
55.38%
sales general and administrative to revenue
22.26
-
0.37
98.32%
14.38
3,737.93%
38.92
170.67%
1.75
95.50%
44.48
2,438.36%
43.90
1.31%
45.37
3.35%
0.23
99.49%
0.93
300.87%
0.68
26.89%
shareholders equity per share
9.31
-
11.75
26.23%
11.89
1.22%
10.64
10.56%
10.81
1.66%
8.16
24.50%
6.84
16.19%
4.61
32.63%
10.54
128.58%
13.13
24.62%
10.55
19.67%
stock based compensation to revenue
4.63
-
0.11
97.62%
6.48
5,788.05%
23.63
264.63%
0.97
95.88%
28.28
2,808.06%
28.97
2.44%
25.81
10.93%
0.12
99.52%
0.58
372.65%
0.45
22.94%
tangible asset value
173.27M
-
289.89M
67.30%
360.67M
24.42%
365.40M
1.31%
407.19M
11.44%
323.00M
20.68%
272.92M
15.50%
184.01M
32.58%
466.04M
153.28%
622.04M
33.47%
595.26M
4.31%
tangible book value per share
9.31
-
11.75
26.23%
11.89
1.22%
10.64
10.56%
10.81
1.66%
8.16
24.50%
6.84
16.19%
4.61
32.63%
10.54
128.58%
13.13
24.62%
10.55
19.67%
working capital
170.82M
-
287.24M
68.16%
355.19M
23.66%
350.29M
1.38%
388.96M
11.04%
416.46M
7.07%
360.66M
13.40%
273.44M
24.18%
551.36M
101.64%
668.95M
21.33%
582.39M
12.94%

All numbers in USD (except ratios and percentages)